Reducing Cardiovascular Risk in the Patient with Elevated Triglycerides

This webinar will cover clinical implications and therapeutic approaches to patients with hypertriglyceridemia. This presentation was created and presented before the results of the REDUCE-IT trial were released.

Learning objectives:

– Understand the effect of hypertriglyceridemia on CHD risk.
– Review treatment strategies to reduce risk of pancreatitis and CHD events.
– Review appropriate therapies for patients with elevated triglycerides.

Presenter(s):
Alan S. Brown, MD FACC FAHA FNLA
Director, Division of Cardiology and the Lipid Clinic Advocate Lutheran General Hospital Clinical Associate Professor, Loyola University Medical Center, Maywood, Illinois

Time of talk: 45 minutes

This is a previously accredited webinar through the American Academy of Family Physicians created in 2017. The material was current as of the recording date. The views and opinions are those of the presenter.